- Home
- SVCO vs CDTX Comparison
SVCO vs CDTX Comparison
Compare SVCO & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVCO
- CDTX
- Stock Information
- Founded
- SVCO 1984
- CDTX 2012
- Country
- SVCO United States
- CDTX United States
- Employees
- SVCO N/A
- CDTX N/A
- Industry
- SVCO
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SVCO
- CDTX Health Care
- Exchange
- SVCO NYSE
- CDTX Nasdaq
- Market Cap
- SVCO 221.9M
- CDTX 242.5M
- IPO Year
- SVCO 2024
- CDTX 2015
- Fundamental
- Price
- SVCO $7.87
- CDTX $21.77
- Analyst Decision
- SVCO Strong Buy
- CDTX Strong Buy
- Analyst Count
- SVCO 6
- CDTX 6
- Target Price
- SVCO $20.83
- CDTX $32.20
- AVG Volume (30 Days)
- SVCO 241.5K
- CDTX 75.1K
- Earning Date
- SVCO 02-14-2025
- CDTX 11-07-2024
- Dividend Yield
- SVCO N/A
- CDTX N/A
- EPS Growth
- SVCO N/A
- CDTX N/A
- EPS
- SVCO N/A
- CDTX N/A
- Revenue
- SVCO $54,307,000.00
- CDTX $44,653,000.00
- Revenue This Year
- SVCO $15.49
- CDTX N/A
- Revenue Next Year
- SVCO $17.07
- CDTX N/A
- P/E Ratio
- SVCO N/A
- CDTX N/A
- Revenue Growth
- SVCO 5.33
- CDTX 44.48
- 52 Week Low
- SVCO $6.14
- CDTX $10.00
- 52 Week High
- SVCO $21.59
- CDTX $24.99
- Technical
- Relative Strength Index (RSI)
- SVCO N/A
- CDTX 61.71
- Support Level
- SVCO N/A
- CDTX $19.24
- Resistance Level
- SVCO N/A
- CDTX $24.99
- Average True Range (ATR)
- SVCO 0.00
- CDTX 2.25
- MACD
- SVCO 0.00
- CDTX -0.17
- Stochastic Oscillator
- SVCO 0.00
- CDTX 69.13
About SVCO SILVACO GROUP INC
Silvaco Group Inc is a provider of technology computer aided design ("TCAD") software, electronic data automation ("EDA") software and semiconductor intellectual property ("SIP"). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the "technology behind the chip" and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.